AI assistant
INSMED Inc — Director's Dealing 2024
Aug 14, 2024
30150_dirs_2024-08-14_03cce8a9-a5ca-4760-9eac-ba9f8490c91b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2024-08-12
Reporting Person: Smith Michael Alexander (Chief Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-12 | Common Stock | M | 11900 | $17.16 | Acquired | 100627 | Direct |
| 2024-08-12 | Common Stock | M | 41640 | $13.91 | Acquired | 142267 | Direct |
| 2024-08-12 | Common Stock | M | 34530 | $17.07 | Acquired | 176797 | Direct |
| 2024-08-12 | Common Stock | S | 67655 | $72.75 | Disposed | 109142 | Direct |
| 2024-08-12 | Common Stock | S | 20415 | $73.65 | Disposed | 88727 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-08-12 | Stock Option (right to buy) | $17.16 | M | 11900 | Disposed | 2027-05-17 | Common Stock (11900) | Direct |
| 2024-08-12 | Stock Option (right to buy) | $13.91 | M | 41640 | Disposed | 2029-01-03 | Common Stock (41640) | Direct |
| 2024-08-12 | Stock Option (right to buy) | $17.07 | M | 34530 | Disposed | 2032-05-11 | Common Stock (34530) | Direct |
Footnotes
F1: This is the weighted average sales price representing 67,655 shares sold at prices ranging from $72.22 to $73.22 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F2: This is the weighted average sales price representing 20,415 shares sold at prices ranging from $73.22 to $74.11 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
F4: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the date of grant.